According to the Centers for Disease Control (CDC), about 1.8 million people aged 40 and above are living with age-related macular degeneration (AMD) in the United States. The CDC also said AMD is the leading cause of permanent impairment of reading or...
Supplementation with lutein and zeaxanthin is a cheap and effective way to cut healthcare spending costs associated with treating age-related macular degeneration, finds a new report from Frost & Sullivan.
A formula supplement containing anti-oxidants plus zinc appears to be cost-effective in slowing the progression of the ‘wet’ form of the most common degenerative eye disease, finds a new study in British Journal of Ophthalmology.
Researchers in Ireland have concluded via a long term trial that supplementation with three carotenoids—lutein, zeaxanthin and meso-zeaxanthin—can improve the visual performance of subjects who had normal vision to start.
Two years of supplementation with lutein and zeaxanthin may boost macular pigment optical density (MPOD) and retinal sensitivity in people with early age-related macular degeneration (AMD), says a new study.
Two years ago lutein player Kemin said it was, “baffled and annoyed” when EFSA rejected its eye health claim that was already approved in France. This week the EU’s food science agency has done it again, but Kemin and its lutein partner DSM, say they...
The significant benefits of adding lutein and zeaxanthin to the AREDS formula for people with low dietary intakes of the carotenoids is an ‘important message’, especially since a large portion of the population has low levels, says the COO of OmniActive.
Adding lutein, zeaxanthin and/or omega-3 fatty acids to the AREDS eye health formula may not offer any additional benefits regarding age-related macular degeneration (AMD) risk, says the much anticipated AREDS2 data.
A combination of lutein, zeaxanthin and omega-3 long-chain polyunsaturated fatty acids may boost the pigment in the retina and help people with age-related macular degeneration (AMD), says new data from Germany.
By Richard Roberts, PhD; Justin Green, PhD; Samanta Maci, MS. Kemin
The statement by eye health researchers that all three carotenoids found in the macula may be needed in a formulation to boost levels of these carotenoids in the macula is 'premature', say leading scientists from Kemin.
Lutein partners DSM and Kemin may submit an article 13.5 lutein-eye health claim dossier after the European Food Safety Authority (EFSA) this week rejected the carotenoid for the third time – but first they want EFSA to explain why it changed the claim...
High dietary intake of lutein and zeaxanthin, compounds with a long history of eye health benefits, may reduce the risk of late-stage age-related macular degeneration (AMD), but they show little effect in the early stages of the disease, claims a new...
In the second part of our special series on eye health, NutraIngredients takes a closer look at the science behind lutein, omega-3 and the other ingredients eyeing a place on the podium for eye health.
Chrysantis announced its branded zeaxanthin has achieved Generally
Regarded As Safe (GRAS) status, opening up the potential for the
ingredient to be used in a new category of functional food and
An article that casts doubts on the effectiveness of eye health
supplements has led industry members and scientists to leap to the
defence of lutein and zeaxathin, which they are confident has been
shown to improve the visual function...